<code id='C9CD50338E'></code><style id='C9CD50338E'></style>
    • <acronym id='C9CD50338E'></acronym>
      <center id='C9CD50338E'><center id='C9CD50338E'><tfoot id='C9CD50338E'></tfoot></center><abbr id='C9CD50338E'><dir id='C9CD50338E'><tfoot id='C9CD50338E'></tfoot><noframes id='C9CD50338E'>

    • <optgroup id='C9CD50338E'><strike id='C9CD50338E'><sup id='C9CD50338E'></sup></strike><code id='C9CD50338E'></code></optgroup>
        1. <b id='C9CD50338E'><label id='C9CD50338E'><select id='C9CD50338E'><dt id='C9CD50338E'><span id='C9CD50338E'></span></dt></select></label></b><u id='C9CD50338E'></u>
          <i id='C9CD50338E'><strike id='C9CD50338E'><tt id='C9CD50338E'><pre id='C9CD50338E'></pre></tt></strike></i>

          fashion

          fashion

          author:Wikipedia    Page View:66
          STAT's Megan Molteni speaks with Feng Zhang in New York on March 21, 2024
          Scientist Feng Zhang, right, is interviewed by reporter Megan Molteni at STAT's Breakthrough Summit East. STAT

          When the first biotech companies emerged to capitalize on the revolutionary genome-editing technology CRISPR, Editas Medicine seemed like the pacesetter. It locked up some of the crucial IP, and had behind it the pioneering scientist Feng Zhang of the Broad Institute as one of its founders.

          But now, a decade later, Editas is seen as lagging behind its peers. CRISPR Therapeutics, in partnership with Vertex Pharmaceuticals, won the race to get the first CRISPR-based medicine across the finish line. Intellia Therapeutics was the first to show that CRISPR editing could be performed inside the body. Editas, meanwhile, has seen a revolving door among its executives.

          advertisement

          So what happened?

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more
          State of the Union pitch: Bigger Medicare drug price negotiations
          State of the Union pitch: Bigger Medicare drug price negotiations

          InhisStateoftheUnionaddress,PresidentBidenwillproposeexpandingseveralofDemocrats'drugpricingreformsi

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          IVF doctors demand details after CooperSurgical lawsuit

          Invitrofertilizationlabstaffpreparesmallpetridishes,eachholdingembryos.(Thissampleimagedoesn'tnecess